@11_iili: #stitch #tiktok #viral #foryou #الحمدلله_دائماً_وابدا ❤️

فقط وسام
فقط وسام
Open In TikTok:
Region: SA
Wednesday 07 January 2026 07:36:40 GMT
835366
37884
962
17031

Music

Download

Comments

f_16.f0
『شــمــدريــكــ』 :
طب زيور ثلاث تسعات الله يستر من الدرجات
2026-01-07 11:13:31
1454
naviaforlana
ᯓ★𝐙𝐨𝐲𝐞|𝙽A𝚟𝚒𝚊ᶠᵃⁿ⋆𐙚 ̊ :
طيب زيرو ثلاث تسعات الله يستر من الدرجات
2026-01-07 10:52:10
371
jijshdmywg0
⁴⁵⁶ 🧤🇸🇦 :
الي خلص اليوم يرقص معي
2026-01-07 08:34:03
70
llsllo1
𐙚 :
للي بيخلصون الخميس:
2026-01-07 11:28:26
32
9.aerz
تريدات انشاءلله ثقه❣️❣️❣️ :
كنت حاسه بضيقهههههههههه الحين تنفستتتت
2026-01-07 08:01:37
82
rlll773
🪽 :
2026-01-07 07:45:44
47
a..2l3
𝐀🐾 :
زيرو ثلاث تسعات رسبنا في الامتحانات🕺🕺
2026-01-07 07:58:22
5
.aj505l
. :
2026-01-07 07:52:11
5
oh_yes_iam_the_diamond17
⊹₊ ⋆〜𝙲𝚊𝚛𝚊𝚝〜⋆₊⊹ :
زيرو ثلاث تسعات الله يستر من الدرجات هههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههههه
2026-01-07 08:56:51
11
selena_69_7
6. ۪۫༉‧₊˚✧𝓼𝓮𝓵𝓮𝓷𝓪✧˚₊‧༉۪۫ :
واخيرا اقدر اقول، طب زيرو ثلاث تسعات هنبدا الاختبارات
2026-01-07 14:43:52
5
.tote.25
𝑇 :
خمسين وثلاث تسعات 💃🏻💃🏻
2026-01-07 07:54:58
5
e6g_1
𝐿𝐸𝐸𝑁🦌 :
والي يخلص يوم الخميس
2026-01-07 08:00:25
11
apple.user62853920
. :
مين باقي يداوم الخميس
2026-01-07 08:46:40
11
yhi.huk
🕸 :
طلاب ثالث متوسط يخلصون الخميس وربيي ظلمم
2026-01-07 08:46:14
21
tl_3232
SH... :
عاشوووووو
2026-01-07 07:44:52
11
user6222732885135
الملكي 💙⚽ :
يارب اجيب بالاختبار 98
2026-01-07 07:58:27
10
r5r225
Dana :
الي خلص اختباراتتتتتت يرقص معيييي
2026-01-07 08:52:11
7
rashidalsubaie24
503🫡🫡🫡 :
خلصنا اختبارات ارقصو معي
2026-01-08 05:02:03
7
qa_hh222
قَطر🐆. :
واحنه بعد اسبوع ونبدييي 😭
2026-01-07 16:17:56
15
8s.83
هواجيس ! :
من قال إننا خلصنا
2026-01-07 12:50:07
14
yayoxo6
... :
ركزو على اسمي 😭❤️‍🔥!!!
2026-01-07 22:28:28
6
ahyon_25
💞هيون🩷 :
طب زيرو ثلاث تسعات نسبتي 96
2026-01-08 10:17:48
6
tala.llll2
معتزله💔 :
باقي شهر ونخلص السنة كاملة 💃🏻💃🏻💃🏻💃🏻💃🏻💃🏻💃🏻
2026-01-07 11:10:35
6
toath.com
Toty :
طب زيرو ثلاث تسعات ما خلصناش الاختبارات
2026-06-17 19:32:40
2
x37iill
★ :
حنا يوم الخميس 😔
2026-01-07 09:54:18
1
To see more videos from user @11_iili, please go to the Tikwm homepage.

Other Videos

Abortion provider Carafem’s phones were ringing nonstop over the weekend after a US federal appeals court reinstated a nationwide requirement that the drug mifepristone, one of two pills used for a medication abortion, must be obtained in person. The decision, handed down on Friday, left patients unsure if they could gain access to their treatment through telehealth. “People are afraid, and they’re angry,” says Carafem’s chief operations officer, Melissa Grant. With the restriction in place, Carafem quickly pivoted to a backup approach. Instead of prescribing the two-drug protocol typical for a medication abortion—mifepristone, which blocks progesterone and prevents the pregnancy from progressing, and then misoprostol, which causes the uterus to contract—the organization began prescribing misoprostol on its own. While slightly less effective than the dual-pill option, it’s been widely used in the past. “We feel comfortable prescribing it,” says Grant. Some Planned Parenthood clinics also pivoted to the misoprostol-only regimen this weekend. “Planned Parenthood providers are doing everything they can to make sure patients know that medication abortion is still safe, legal, and available,” says Danika Severino, vice president of care and access at Planned Parenthood Federation of America. On Monday, the Supreme Court offered a temporary reprieve, pausing the appeals court ruling for a week. The measure allows patients to once again get mifepristone through virtual clinics at least until May 11, when SCOTUS will take another look at the case. Carafem and Planned Parenthood say they are prepared to shift back to misoprostol-only if necessary. Other providers, including the digital abortion clinic HeyJane, have confirmed that they will also take that approach if necessary. Mifepristone was developed in the 1980s in France and has been extensively studied for safety and efficacy. It was approved by the Food and Drug Administration in 2000. Tap the 🔗 in bio to read the full story.
Abortion provider Carafem’s phones were ringing nonstop over the weekend after a US federal appeals court reinstated a nationwide requirement that the drug mifepristone, one of two pills used for a medication abortion, must be obtained in person. The decision, handed down on Friday, left patients unsure if they could gain access to their treatment through telehealth. “People are afraid, and they’re angry,” says Carafem’s chief operations officer, Melissa Grant. With the restriction in place, Carafem quickly pivoted to a backup approach. Instead of prescribing the two-drug protocol typical for a medication abortion—mifepristone, which blocks progesterone and prevents the pregnancy from progressing, and then misoprostol, which causes the uterus to contract—the organization began prescribing misoprostol on its own. While slightly less effective than the dual-pill option, it’s been widely used in the past. “We feel comfortable prescribing it,” says Grant. Some Planned Parenthood clinics also pivoted to the misoprostol-only regimen this weekend. “Planned Parenthood providers are doing everything they can to make sure patients know that medication abortion is still safe, legal, and available,” says Danika Severino, vice president of care and access at Planned Parenthood Federation of America. On Monday, the Supreme Court offered a temporary reprieve, pausing the appeals court ruling for a week. The measure allows patients to once again get mifepristone through virtual clinics at least until May 11, when SCOTUS will take another look at the case. Carafem and Planned Parenthood say they are prepared to shift back to misoprostol-only if necessary. Other providers, including the digital abortion clinic HeyJane, have confirmed that they will also take that approach if necessary. Mifepristone was developed in the 1980s in France and has been extensively studied for safety and efficacy. It was approved by the Food and Drug Administration in 2000. Tap the 🔗 in bio to read the full story.

About